Julie De Walsche, Pharm D, MSc
About Julie De Walsche, Pharm D, MSc
Julie De Walsche, Pharm D, MSc, is a Senior Global Trial Specialist at Bristol-Myers Squibb in Boudry District, Neuchâtel, Switzerland, with extensive experience in managing clinical trials across multiple therapeutic areas.
Current Title and Role
Julie De Walsche is currently a Senior Global Trial Specialist at Bristol-Myers Squibb. She operates from Boudry District, Neuchâtel, Switzerland. In this role, she has been involved in the set-up and close-out of clinical trials on an international scale, contributing extensively to the company's Global Development Operations department since November 2019.
Past Experience at Celgene
Julie De Walsche has accumulated significant experience at Celgene, where she held multiple roles over several years. From 2017 to 2019, she was a Global Senior Clinical Trial Associate at the International Headquarters in Boudry, Switzerland. Previously, she served as a Global Clinical Trial Associate & IIT Contract Coordinator at the same location from 2015 to 2017. She also worked as a Global Senior Clinical Trial Associate for a brief period in 2019 at the International Headquarters in Marin, Switzerland.
Earlier Career Roles
Earlier in her career, Julie De Walsche gained valuable experience as a trainee at various institutions. In 2014, she worked as a Clinical Trial Scientist at Actelion Global Headquarters in Basel, Switzerland, for five months. That same year, she spent two months as a Clinical Study Coordinator trainee at med BioMed in University Hospital's Pneumology department in Montpellier, France. In 2013, she also served as a Clinical Study Coordinator trainee for two months at the Clinical Investigation Center at University Hospital in Montpellier, France.
Educational Background
Julie De Walsche studied at the Medical School in Montpellier, France, where she earned a Master of Science (MSc) in Design, Evaluation, and Management of Clinical Trials from 2013 to 2014. Prior to that, she achieved her Doctor of Pharmacy (PharmD) degree from the College of Pharmacy in Lille, France, completing her studies in 2015, which spanned a period of 10 years from 2005 to 2015.
Specializations and Expertise
Julie De Walsche specializes in managing interventional phase II, III, and non-interventional PASS studies across multiple therapeutic areas. Her expertise lies particularly in the fields of Hematology and Cellular Therapy within Oncology. Throughout her career, she has garnered extensive experience in clinical research, handling projects both at the site level and within international pharmaceutical companies.